Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,130.00
(
0.48%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
99.40
(
-1.25%
)
Bitcoin
74,634.86
(
0.94%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: mcbio post# 105815

Thursday, 10/07/2010 10:48:42 PM

Thursday, October 07, 2010 10:48:42 PM

Post# of 257253
ANTH’s Varespladib is an anti-inflammatory, not an anticoagulant. To assess whether ANTH is a good investment, I would want to know the outcome of the phase-2 ACS study described in http://clinicaltrials.gov/ct2/show/NCT00743925 .

The clinicaltrials.gov entry says this study finished in Apr 2010, but it does not contain the results.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now